Beyond One Option for the Treatment of Severe Traumatic Brain Injury
NCT ID: NCT06787040
Last Updated: 2025-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2024-01-01
2025-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke
NCT06801457
Clinical Outcome Following Early Decannulation of Severe Acquired Brain Injury Patients
NCT06167538
Security and Effectiveness Assessment of Locking Systems in Ventriculostomy for Traumatic Brain Injury
NCT06772155
Safety and Efficacy of Remote Ischemic Conditioning in Patients with Severe Stenosis or Occlusion of Anterior Intracranial Circulation Vessels
NCT06823128
Detection of Cerebral Ischemia With Artificial Intelligence.
NCT03919370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a prospective, observational, before and after study, pilot investigation of the treatment process and outcomes for patients with TBI, who are transported by any means to a medical center for treatment. Data will be collected for each patient through the four phases of prehospital, ED, neurosurgery, and ICU, or until the patient expires. Data will be abstracted from hospital medical records.
From the initiation of the "before" phase, data for each patient will be collected from the initial patient encounter to hospital discharge, for 3 months. The BOOTStraP protocol will be implemented during the month following the end of initial data collection. After implementation ("after" phase), data for each patient will be collected from initial patient encounters to hospital discharge, for 3 months. The treatment protocols to be implemented at each center are available in the open-access published paper at the NIH PMC website: (https://pmc.ncbi.nlm.nih.gov/articles/PMC7055642/).
Each day during active data collection, the Data Collector (DC) for each site arrives at the hospital, accesses the ED records, and identifies patients admitted during the previous 24 hours who may meet inclusion criteria for the study. The DC ascertains information about the potential included patients from ED records and attending caregivers, and identifies those screened and excluded, and those screened and included. Data are transcribed from ED records and caregiver interactions directly into a web-based database. The DC completes data abstraction for included patients. The DC identifies the location and status of newly included patients, and transcribes data about each patient into the database, up to and including the current status. After completing data abstraction for new patients entered within the previous 24 hours, the DC identifies the location and status of patients previously included in the study, and transcribes data about each patient into the database, up to and including the current status. Each day during active data collection, the Study Coordinator (SC) accesses the electronic records and reviews new data entries for errors and missing data. Twice monthly, the SC visits each study site, compares abstracted data with chart records, and meets with the site DC to discuss errors and missing data. The SC and DC make any revisions together, directly into the database. During these visits, the SC records narrative information about reasons for errors and missing data, what is working and not working, and the DCs' perspectives on the barriers to and facilitators of conducting the study. The SC transcribes this narrative information into a qualitative data collection/analysis database. Categorical data will be summarized as frequencies and percentages, while continuous variables will be summarized using mean, median, minimum, maximum, and 25th and 75th percentiles. We will record narrative information from personnel at each site to investigate the barriers to and facilitators of data collection and intervention implementation. These data will be entered into a qualitative data analysis instrument, and Grounded Theory will be utilized to identify common themes. Adherence will be derived by tracking if each recommended BOOTStraP resource was available (yes/no), and if yes, whether it was utilized (yes/no). The analysis of adherence will be presented by treatment phase (prehospital, emergency department, neurosurgery, and intensive care unit). The percentage of adherence to the BOOTStrap protocol will be used as a summary statistic. The study is descriptive in nature and outcome data will be summarized descriptively by phase (before and after). The analysis will explore correlations between adherence levels by phase and individual treatments on outcome data. No hypothesis will be tested. The sample size for the study was determined based on feasibility and no formal calculation of power was performed. Implementation of BOOTStraP should increase survival to hospital discharge, and improve GOS-E at discharge. We expect there will be many barriers to implementation, especially in the pre-hospital stage. We expect adherence to protocols to be modest. This study will provide the basis to plan for a larger multi-center international study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before Implementation
Patients managed before the implementation of the stratified protocol for TBI care in the Emergency Room, Surgery, and ICU
No interventions assigned to this group
After Implementation
Patients managed after the implementation of the stratified protocol for TBI care in the Emergency Room, Surgery, and ICU
Resource-Stratified Protocol
The interventions are a set of protocols that accounts for varying levels of resources available at any given time for patients with severe traumatic brain injury across prehospital, ED, neurosurgery, and ICU. Protocols are available in the NIH-PMC website at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7055642/
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resource-Stratified Protocol
The interventions are a set of protocols that accounts for varying levels of resources available at any given time for patients with severe traumatic brain injury across prehospital, ED, neurosurgery, and ICU. Protocols are available in the NIH-PMC website at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7055642/
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical indications of TBI
* GCS ≤ 8 on hospital arrival, or within 48 hours of admission OR GCS ≥9 on hospital arrival, but who are either admitted to the ICU or undergo surgery within 48 hours of admission
Exclusion Criteria
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NIHR Global Health Research Group on Neurotrauma
UNKNOWN
Gates Cambridge
OTHER
Meditech Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andres M. Rubiano
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andres M Rubiano, MD
Role: STUDY_DIRECTOR
Meditech Foundation
Peter J Hutchinson, MD, PhD
Role: STUDY_DIRECTOR
University of Cambridge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Uros Neiva
Neiva, Huila Department, Colombia
Clinica Putumayo
Puerto Asís, Putumayo Department, Colombia
Clinica La Sagrada Familia
Armenia, Quindío Department, Colombia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rubiano AM, Vera DS, Montenegro JH, Carney N, Clavijo A, Carreno JN, Gutierrez O, Mejia J, Ciro JD, Barrios ND, Soto AR, Tejada PA, Zerpa MC, Gomez A, Navarrete N, Echeverry O, Umana M, Restrepo CM, Castillo JL, Sanabria OA, Bravo MP, Gomez CM, Godoy DA, Orjuela GD, Arias AA, Echeverri RA, Paranos J. Recommendations of the Colombian Consensus Committee for the Management of Traumatic Brain Injury in Prehospital, Emergency Department, Surgery, and Intensive Care (Beyond One Option for Treatment of Traumatic Brain Injury: A Stratified Protocol [BOOTStraP]). J Neurosci Rural Pract. 2020 Jan;11(1):7-22. doi: 10.1055/s-0040-1701370. Epub 2020 Mar 3.
Griswold DP, Carney N, Ballarini NM, Fernandez LL, Kolias A, Hutchinson PJ, Rubiano AM. Protocol for a Multicenter, Prospective, Observational Pilot Study on the Implementation of Resource-Stratified Algorithms for the Treatment of Severe Traumatic Brain Injury Across Four Treatment Phases: Prehospital, Emergency Department, Neurosurgery, and Intensive Care Unit. Neurosurgery. 2022 Aug 1;91(2):355-359. doi: 10.1227/neu.0000000000002004. Epub 2022 May 3.
Jayaraman S, Ozgediz D, Miyamoto J, Caldwell N, Lipnick MS, Mijumbi C, Mabweijano J, Hsia R, Dicker R. Disparities in injury mortality between Uganda and the United States: comparative analysis of a neglected disease. World J Surg. 2011 Mar;35(3):505-11. doi: 10.1007/s00268-010-0871-z.
Rubiano AM, Carney N, Chesnut R, Puyana JC. Global neurotrauma research challenges and opportunities. Nature. 2015 Nov 19;527(7578):S193-7. doi: 10.1038/nature16035.
Passmore JW, Nguyen LH, Nguyen NP, Olive JM. The formulation and implementation of a national helmet law: a case study from Viet Nam. Bull World Health Organ. 2010 Oct 1;88(10):783-7. doi: 10.2471/BLT.09.071662. Epub 2010 Aug 30.
Global Status Report on Road Safety 2018: Summary. World Health Organization; 2018:20.
Alarcon JD, Gich Saladich I, Vallejo Cuellar L, Rios Gallardo AM, Montalvo Arce C, Bonfill Cosp X. [Mortality in Colombia traffic accidents. Comparative study with other countries]. Rev Esp Salud Publica. 2018 Jul 5;92:e201807040. Spanish.
Liu BC, Ivers R, Norton R, Boufous S, Blows S, Lo SK. Helmets for preventing injury in motorcycle riders. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004333. doi: 10.1002/14651858.CD004333.pub3.
Association WM. Declaration of Helsinki. Accessed November 26, 2021. https://www.wma.net/ policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research- involving-human-subjects/
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1272-0282
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.